Brentuximab vedotin (BV) in recurrent and refractory Hodgkin Lymphoma (HL) in children. Experience of Polish Pediatric Leukemia/Lymphoma Study Group

Autor:	A Wziatek, Małgorzata Stolarska, A Brozyna, Justyna Kwasnicka, Karolina Zielezińska, Tomasz Klekawka, Angelina Moryl-Bujakowska, K Smalisz, Borys Przybyszewski, Radosław Chaber, Andrzej Kołtan, Teresa Stachowicz-Stencel, Walentyna Balwierz
Rok vydání:	2020
Předmět:	Pediatric leukemia Oncology medicine.medical_specialty business.industry Internal medicine Refractory Hodgkin Lymphoma Medicine business Brentuximab vedotin medicine.disease medicine.drug Lymphoma
Zdroj:	Klinische Pädiatrie.
ISSN:	1439-3824
DOI:	10.1055/s-0040-1701899
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d257ff1400457c8bd4e5af009bc4391c https://doi.org/10.1055/s-0040-1701899 Zobrazit plný text záznamu